Grants Search Results

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: New Approaches to Neuroblastoma Therapy (NANT) Consortium. For a description of this project, see the consortium grant made to the lead institution: Children's Hospital Los Angeles, Los Angeles, CA.

High-Risk neuroblastoma (HR-NB) is an aggressive pediatric cancer, with only half of patients surviving. New Approaches to Neuroblastoma Therapy (NANT) headquartered at Children's Hospital Los Angeles is the only group focused on new treatments based on lab data for HR-NB. NANT includes a team of 18 children's hospitals across nationally and internationally working together to design new treatments, treat patients, and use what is learned to design the next treatments. New treatments include helping patients’ own immune system kill tumor by increasing and activating immune cells. Another treatment uses radiation therapy focused on the tumor combined with medicines to help the immune system recognize tumor. Trials include special tests on patients' blood and bone marrow to understand how treatments work, find tiny amounts of tumor and new therapy targets. NANT trials help kids with aggressive NB that has come back. Funds administered by Children's Hospital Los Angeles.

This grant is named for the LukeStrong a Force Against Neuroblastoma Childhood Cancer Fund. When Luke was 5 years old, he was diagnosed with high-risk neuroblastoma. He is now in his teens and still in active treatment for relapsed neuroblastoma. Since 2014 Luke’s “Never tell me the odds” attitude has inspired his family and friends to shave their heads, fundraise with St. Baldrick’s, and help conquer childhood cancers.

This grant supports a pediatric-focused Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Fortunately, the majority of children with cancer are cured with the standard or primary treatment of their cancer. This is largely due to improvement in outcomes over time through cooperative group studies through a national organization called Children's Oncology Group (COG). COG studies are very labor intensive and therefore require significant amounts of resources and research staff to ensure all children with cancer eligible for COG studies are able to be enrolled on these studies. This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Clinical research associates are the cornerstone of clinical research who helps to open new clinical trials, maintain trials, and enroll patients. This grant supports a Clinical Research Associates at El Paso Children's hospital to facilitate clinical research in children with cancer.

This grant supports a data manager who will help ensure clinical trial data is complete, timely, and of the highest quality. This will allow the clinical research coordinators to focus on enrolling patients, ensuring more children have access to the most cutting edge treatments, often their best hope for a cure.

This grant supports a survivorship program Clinical Research Associate to ensure that more kids are offered enrollment onto appropriate registry, late effects, and supportive care clinical trials.

This grant supports an Adolescent Young Adult (AYA) Clinical Research Coordinator to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

St. Joseph's Children's Hospital serves a diverse, economically-challenged population. This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure. The Clinical Research Associate will help increase patients' participation in pediatric oncology clinical trials and will help add to the knowledge base around minority patients who are often underrepresented in research.

The Loma Linda University Children's Hospital (LLUCH) services a four-county region (San Bernardino, Riverside, Inyo and Mono Counties). For the 1.3 million children living in this region, 25% come from families that live in poverty and are uninsured. This population represents 80% of the children treated here. This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure. The participation of this patient population in clinical trials is critical for the identification of therapies that can alleviate this health disparity and effectively treat all children.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

New Mexico is a unique state with a largely rural, underserved, and multicultural patient population. This grant supports a clinical research professional to ensure that more kids can be treated on clinical trials, often their best hope for a cure. Additionally, with increased enrollment of our unique patient population in these national and international clinical trials the University of New Mexico Pediatric Oncology Division will increase the diversity of patient representation in these trials.